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Abstract
Background: Nitric oxide (NO) can be both pro- and anti-apoptotic in various cell types,
including macrophages. This apparent paradox may result from the actions of NO-related species
generated in the microenvironment of the cell, for example the formation of peroxynitrite
(ONOO-). In this study we have examined the ability of NO and ONOO- to evoke apoptosis in
human monocyte-derived macrophages (MDMϕ), and investigated whether preconditioning by
cyclic guanosine monophosphate (cGMP) is able to limit apoptosis in this cell type.
Methods: Characterisation of the NO-related species generated by (Z)-1- [2-(2-aminoethyl)-N-
(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate (DETA/NO) and 1,2,3,4-oxatriazolium, 5-amino-
3-(3,4-dichlorophenyl)-, chloride (GEA-3162) was performed by electrochemistry using an isolated
NO electrode and electron paramagnetic resonance (EPR) spectrometry. Mononuclear cells were
isolated from peripheral blood of healthy volunteers and cultured to allow differentiation into
MDMϕ. Resultant MDMϕ were treated for 24 h with DETA/NO (100 – 1000 μM) or GEA-3162
(10 – 300 μM) in the presence or absence of BAY 41–2272 (1 μM), isobutylmethylxanthine (IBMX;
1 μM), 1H- [1,2,4]oxadiazolo [4,3-a]quinoxalin-1-one (ODQ; 20 μM) or 8-bromo-cGMP (1 mM).
Apoptosis in MDMϕ was assessed by flow cytometric analysis of annexin V binding in combination
with propidium iodide staining.
Results: Electrochemistry and EPR revealed that DETA/NO liberated free NO radical, whilst
GEA-3162 concomitantly released NO and O2-, and is therefore a ONOO- generator. NO (DETA/
NO) had no effect on cell viability, but ONOO- (GEA-3162) caused a concentration-dependent
induction of apoptosis in MDMϕ. Preconditioning of MDMϕ with NO in combination with the
phosphodiesterase inhibitor, 3-Isobutyl-1-methylxanthine (IBMX), or the NO-independent
stimulator of soluble guanylate cyclase, BAY 41–2272, significantly attenuated ONOO--induced
apoptosis in a cGMP-dependent manner.
Conclusion: These results demonstrate disparities between the ability of NO and ONOO- to
induce apoptosis in human MDMϕ. Furthermore, this study provides evidence for a novel cGMP-
dependent pre-conditioning mechanism to limit ONOO--induced apoptosis in human MDMϕ.
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Background
Apoptosis is a highly regulated and fundamental biologi-
cal process governing cell survival. During apoptosis, the
integrity of the cell membrane is maintained, therefore
preventing release of the histotoxic cell contents. Because
apoptotic cells are instantly recognised by phagocytes and
removed from the inflammatory site, successful apoptosis
is now recognised to be crucial to the resolution of inflam-
mation. Failure of inflammatory cells to undergo apopto-
sis, or failure of subsequent phagocytic removal of
apoptotic cells is believed to result in incomplete resolu-
tion and an exacerbation of the inflammatory response
[1-4]. Thus, apoptosis is a non-inflammatory mechanism
for the removal of inflammatory cells from a site of tissue
damage.
The propensity of a cell to undergo apoptosis is deter-
mined by the net balance of many pro- and anti-apoptotic
exogenous and endogenous factors [5-7]. The signalling
molecule, nitric oxide (NO), has previously been reported
to induce apoptosis in various cell types, including mac-
rophages [8-12]. However, the role of NO in apoptosis is
complicated by a number of reports indicating that it can
be both pro- and anti-apoptotic [13-15]. The generally
accepted paradigm is that lower NO concentrations pro-
duced constitutively by endothelial NO synthase (eNOS)
and neuronal NO synthase (nNOS) are cytoprotective via
primarily cGMP-dependent mechanisms, whilst higher,
supraphysiological concentrations generated in some
pathologies by the inducible form of NOS (iNOS) medi-
ate apoptosis via mechanisms independent of cGMP sig-
nalling [16].
This apparent paradox may be explained, at least in part,
by the production of intermediary NO-related species,
with the ultimate outcome of any NO-mediated response
being dependent on the precise NO-related species
formed in the microenvironment, as well as the cell type
in question. In biological systems NO often reacts with
superoxide anions (O2•-), resulting in the formation of the
powerful oxidising agent, peroxynitrite (ONOO-) [17-20].
ONOO- has been shown to induce apoptosis in human
inflammatory cells, such as neutrophils [21,22].
Disparities between the sensitivity of different cell types to
apoptosis induced by NO (or NO-related species), sug-
gests the presence of protective mechanisms in those cell
types resistant to NO-evoked apoptosis. Such protective
mechanisms may depend on the anti-apoptotic qualities
of NO itself. Indeed, non-toxic concentrations of NO, and
agents that act to elevate cGMP independently of NO,
have been demonstrated to protect rodent macrophages
and vascular smooth muscle cells (VSMC) against subse-
quent NO-induced cell death [23-26].
Here, we test the hypothesis that the NO-related species,
ONOO-, but not NO, induces apoptosis in human macro-
phages derived from the monocyte population of periph-
eral blood. Furthermore, we investigate whether low
concentrations of NO, and the novel NO-independent
stimulator of soluble guanylate cyclase, BAY 41–2272, are
able to precondition human macrophages against subse-
quent ONOO--induced apoptosis.
Methods
Electrochemical Detection of NO
NO radical released in Iscove's modified Dulbecco's tissue
culture medium (IMDM; Gibco Life Technologies, UK)
from (Z)-1- [2-(2-aminoethyl)-N-(2-ammonioe-
thyl)amino]diazen-1-ium-1,2-diolate (DETA/NO; Axxora
Ltd, UK) and 1,2,3,4-oxatriazolium, 5-amino-3-(3,4-
dichlorophenyl)-, chloride (GEA-3162; Axxora Ltd, UK)
was measured by an isolated NO electrode (Iso-NO II,
World Precision Instruments, UK). NO production by
DETA/NO (300 μM) was recorded for 30 min.
Superoxide dismutase (SOD; 50–500 U.ml-1; Sigma-
Aldrich, UK) was added cumulatively in stepwise incre-
ments to unmask NO produced by GEA-3162 (300 μM)
[21]. Each bolus addition of SOD was added to the elec-
trode chamber once the signal from the previous addition
of SOD had reached a plateau, usually after approximately
3–5 min. Alternatively, GEA-3162 and 500 U.ml-1 SOD
were introduced simultaneously to the electrode chamber
and the signal recorded until it decayed to baseline.
Finally, because the structurally similar compound, SIN-1,
can generate ONOO- in vitro, but NO in the presence of
biological tissues [27], we investigated whether GEA-3162
could generate NO in the presence of a suspension of
monocyte-derived macrophages (1 × 106 cells/ml).
The NO scavenger, haemoglobin (Hb; 5 μM) [28], was
introduced to the electrode chamber to confirm NO gen-
eration in experiments where the signal had not decayed
to baseline at the end of the incubation period.
Electron Paramagnetic Resonance Studies
The concentration of oxidising free radical species gener-
ated by GEA-3162 in the presence or absence of SOD was
assessed in IMDM tissue culture medium by electron par-
amagnetic resonance (EPR) spectrometry (electron spin
resonance). GEA-3162 (10–300 μM) was incubated for 30
min at 37°C in the presence or absence of SOD (500
U.ml-1) plus the chemical spin trap Tempone-H hydro-
chloride (1 mM; Axxora, UK; prepared in water containing
EDTA (10 mM) [29,30]. The intensity of the EPR signals
corresponding to the formation of the radical adduct, 4-
oxo-tempo (triplet centred around 3360 G), were
recorded using a Miniscope MS100 X-band spectrometer
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(Magnettech, Germany) with the following parameter set-
tings: field sweep 51.2 G, microwave frequency 9.5 GHz,
microwave power 20 mW, modulation amplitude 1500
mG. Control experiments, consisting of tempone-H in
IMDM in the absence of radical-generating compounds,
were found to generate small signals due to the auto-oxi-
dation of tempone-H to 4-oxo-tempo; these control sig-
nals were subtracted from the corresponding
experimental signals. There experiments were repeated
with GEA-3162 which had undergone spontaneous
decomposition at 37°C for 7 days.
Cell Isolation and Culture
Mononuclear cells (MNC) and polymorphonuclear cells
were isolated from human blood as previously described
[31,32]. Briefly, whole, citrated blood was centrifuged
(200 × g; 20 min) and platelet-rich plasma (PRP) aspi-
rated. Leukocytes were separated from erythrocytes by
dextran sedimentation, then further divided into MNC
and granulocyte populations by centrifugation through a
discontinuous Percoll® (Pharamcia, UK) gradient (720 × g;
20 min). MNC were harvested at the 55:68% interface and
re-suspended at a density of 4 × 106 cells/ml in IMDM sup-
plemented with penicillin and streptomycin (both 100
U.ml-1), prior to enrichment for monocytes by selective
adherence to 48-well (2 × 106 cells/well) tissue culture
plates for 1 h at 37°C in 5% CO2. Adherent monocytes
were washed three times in phosphate buffered saline
(PBS) and then allowed to differentiate into MDMϕ for 5
days (37°C; 5% CO2) in IMDM containing penicillin/
streptomycin and 10% autologous serum prepared by
recalcification of  PRP. Medium was replaced every 2–3
days throughout the differentiation period.
Experimental Protocols
In order to investigate the effect of NO radical and
ONOO- on cell viability, MDMϕ were treated for 24 h
with the NO donor, DETA/NO (100–300 μM), the
ONOO- generator, GEA-3162 (10–300 μM), or vehicle
control (DMSO; 1%) prior to assessment of apoptosis and
necrosis by flow cytometry as described below. The exper-
iments were repeated for GEA-3162 in the presence of the
anti-oxidant enzymes SOD, or a combination of SOD
plus catalase (both 500 U.ml-1). In order to investigate the
actions of the breakdown products of the compound,
additional experiments were conducted with GEA-3162
which had been allowed to decompose at 37°C for 7 days.
The known pro-apoptotic agent, gliotoxin (1 μg.ml-1;
Sigma Aldrich, UK) was used as a positive control for the
assay [33-35].
To investigate the role of NO:cGMP signalling in ONOO-
-induced apoptosis, MDMϕ were pre-treated for 24 h with
DETA/NO (10 μM) plus either the NO-independent sGC
stimulator, BAY 41–2272 (1 μM; Bayer, Germany; [36], or
the non-specific phosphodiesterase (PDE) inhibitor, 3-
isobutyl-1-methylxanthine (IBMX; 1 μM; Axxora, UK).
BAY 41–2272 was used in combination with DETA/NO
(10 μM) because recent evidence has suggested that,
rather than acting via direct stimulation of sGC, the
actions of this compound are a result of the synergistic
effects of inhibition of PDE V coupled with sensitisation
of sGC toward endogenous NO [37,38]. As IBMX also
raises intracellular cGMP by inhibiting its breakdown,
DETA/NO is used to provide the initial stimulus for cGMP
production because human macrophages are unlikely to
generate enough endogenous NO to result in cellular
cGMP production. The ability of the NO:cGMP pathway
to inhibit ONOO- dependent apoptosis was further inves-
tigated by pre-treating MDMϕ for 24 h with the cell per-
meable cGMP analogue, 8-bromo-cGMP (1 mM), or a
higher concentration of DETA/NO (300 μM) in the pres-
ence or absence of the sGC inhibitor, 1-H- [1,2,4]oxadia-
zolo [4,3-a]quinoxalin-1-one (ODQ; 20 μM).
Following this pre-treatment period, cells were washed
twice in PBS to remove pre-treatment compounds prior to
incubation for a further 24 h in the presence of the
ONOO- generator, GEA-3162 (100 μM). At this concen-
tration, GEA-3162 induces significant apoptosis in
MDMϕ without causing necrosis. Finally, a set of cells
were treated for the final 24 h period only with the apop-
totic agent, gliotoxin (1 μg.ml-1), which serves as a posi-
tive control for the assay.
Flow Cytometric Analysis of Annexin V Binding and 
Propidium Iodide Staining
Cell death was assessed by flow cytometric detection of
fluorescein isothiocyanate (FITC)-conjugated annexin V
binding to phosphatiylserine (PS) exposed on the surface
of apoptotic cells, or propidium iodide (PI) staining of
late apoptotic/necrotic cells. Following the experimental
protocol detailed above, cells were removed from tissue
culture plates (0.25% trypsin with EDTA) and recovered
cell suspensions incubated for 10 min on ice in the pres-
ence of FITC-annexin V in annexin V-binding buffer (pre-
pared as a 1:500 dilution of annexin V in Hank's balanced
salt solution (HBSS) containing 5 mM CaCl2). Following
this incubation period, PI (final concentration 2 μg.ml-1)
was added to the cell suspension/annexin V binding
buffer mix for 1 min prior to analysis by Coulter EPICS XL
flow cytometer (Beckman Coulter, USA) equipped with
EXPO™ 32 data analysis software.
Quantification of cGMP
Levels of cGMP produced by MDMϕ following incubation
with DETA/NO in the absence and presence of BAY 41–
2272 or IBMX were measured by enzyme-linked immuno-
sorbant assay (ELISA; R&D Systems, UK) according to the
manufacturer's instructions. Briefly, cell culture superna-
tants were aspirated and adherent cells lysed (2% Triton X
100). Recovered solutions were acidified (0.1 M HCl) and
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acetylated prior to performing the assay. Optical density
(405 nm) was measured by a Multiskan Ascent plate
reader and the concentration of cGMP was calculated
from a standard curved produced from serial dilutions of
acetylated cGMP solutions (0.08 – 50 pmol.ml-1). All
standards and samples were assayed in duplicate.
Statistics
Data are expressed throughout as mean ± SEM, with n val-
ues as indicated. Statistical tests are described in figure leg-
ends and were performed using GraphPad Prism software
version 3.03 (GraphPad Software Inc., San Diego, USA).
Results were considered to be statistically significant when
P < 0.05.
Results
NO Release from DETA/NO and GEA-3162
DETA/NO (300 μM) generated a slow and prolonged NO
release in IMDM that remained steady throughout a 30
min recording period. Introduction of the NO scavenger,
haemoglobin (Hb; 5 μM), to the electrode chamber suc-
cessfully quenched the signal from the electrode, confirm-
ing NO release from DETA/NO (figure 1A).
In common with previous findings [21], GEA-3162 (300
μM) failed to generate a detectable NO signal except in the
presence of the superoxide scavenger, SOD (50 – 500
U.ml-1), when stepwise, incremental concentrations of
NO were detectable. MDMϕ did not alter the inability of
GEA-3162 to liberate NO in the absence of SOD, and did
not alter concentration of NO released from GEA-3162 in
the presence of SOD. Hb quenched the signal from GEA-
3162 (figure 1B). In the presence of SOD to unmask the
NO released by GEA-3162, NO decayed from a max value
of 2.2 μM over a period of ~4 h (figure 1C).
ONOO- Generation by GEA-3162
GEA-3162 generated an EPR signal consistent with the
production of the radical adduct, 4-oxo-tempo. SOD sig-
nificantly attenuated the intensity of this signal by a max-
imum of 61% (figure 2). Incubation of GEA-3162 at 37°C
for 7 days resulted in partial decomposition of the com-
pound. The EPR signal from GEA-3162 treated in this way
was diminished, but not completely abolished; the signal
was reduced from an intensity of 6894 ± 810 (n = 6) to
2939 ± 650 (n = 3). This remaining signal was also
quenched by SOD to 1443 ± 290.
Quantification of cGMP
Levels of cGMP were undetectable (< 0.08 pmol.ml-1) in
vehicle treated control MDMϕ. Those cells that had been
treated with DETA/NO plus BAY 41–2272 or IBMX gener-
ated 0.325 and 0.40 pmol.ml-1 cGMP per 1 × 106 cells
respectively. Levels of cGMP generated by DETA/NO
alone were below the limit of detection of the assay.
Peroxynitrite, But Not NO, Induces Apoptosis in Human 
MDMϕ
The NO donor, DETA/NO, at concentrations of up to 1
mM, had no affect on the levels of annexin V binding or
PI staining in human MDMϕ. In contrast, the ONOO-
NO generation by DETA/NO and GEA-3162 measured by isolated NO electrode  – NO liberated by DETA/NO (300 μM) r co ded for 30 min (n = 6)Figu  1
NO generation by DETA/NO and GEA-3162 meas-
ured by isolated NO electrode A – NO liberated by 
DETA/NO (300 μM) recorded for 30 min (n = 6). B – GEA-
3162 (300 μM) failed to liberate free NO in solution except 
in the presence of SOD. Each addition of SOD is added 
approximately 3 – 5 min following the previous addition. The 
concentration of NO liberated in the presence of SOD was 
unchanged by MDMϕ (n = 3). Arrows indicate addition of 
Hb. C – In the presence of 500 U.ml-1 SOD, GEA-3162 (300 
μM) liberated NO over a period of approximately 4 h (n = 
6).
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generator, GEA-3162 (10–300 μM) [21], caused a concen-
tration-dependent induction of apoptosis in human
MDMϕ, as demonstrated by an increase in annexin V
binding (figure 3). At concentrations up to 100 μM, the
increase in annexin V binding occurred in the absence of
significant PI staining. However, at higher concentrations
(300 μM) a significant level of PI staining was also
observed. Therefore, in order to specifically induce apop-
tosis, a concentration of 100 μM GEA-3162 was selected
for subsequent experiments. Whereas fresh GEA-3162
(100 μM) induced a maximum of 61 ± 7% (n = 9) apop-
tosis, this was reduced to 39 ± 9% (n = 3) following treat-
ment with partially decomposed GEA-3162.
The level of apoptosis (annexin V binding) induced by
GEA-3162 (10–300 μM) was further enhanced when
MDMϕ were treated with GEA-3162 in the presence of
SOD (figure 3C). The additional elevation of apoptosis
induced by SOD was suppressed when MDMϕ were
treated with GEA-3162 in the presence of a combination
of SOD plus catalase (figure 3C). This combination did
not, however, reduce overall levels of apoptosis induced
by GEA-3162. Neither SOD nor catalase had any impact
on the level of PI staining.
cGMP Signalling Protects MDMϕ Against Peroxynitrite 
Induced Apoptosis
Control sets of cells demonstrated that 24 h pre-treatment
of MDMϕ with DETA/NO (10 μM) in combination with
BAY 41–2272 or IBMX (both 1 μM) had no effect on cell
viability compared to untreated cells. Similarly, higher
concentrations of DETA/NO (300 μM) alone or in combi-
nation with the sGC inhibitor, ODQ (20 μM), did not
affect cell viability (figure 4A).
Treatment with GEA-3162 (100 μM) alone induced apop-
totic cell death (annexin V binding) in MDMϕ. However,
levels of apoptosis were significantly attenuated in those
cells that had been subjected to previous 24 h pre-treat-
ment with DETA/NO (10 μM) in combination with BAY
41–2272 or IBMX (P < 0.05 for both treatments compared
to GEA-3162 treated cells; figure 4). Pre-treatment with
the cell permeable cGMP analogue, 8-bromo-cGMP, also
significantly attenuated subsequent GEA-3162 induced
apoptosis. Similarly, DETA/NO (300 μM) afforded pro-
tection against GEA-3162 induced apoptosis and this pro-
tection was reversed in the presence of ODQ (figure 4).
Discussion
This study reveals disparities between the ability of NO
radical and NO-related species to induce apoptosis in
human macrophages. Our study highlights the opposing
effects of ONOO- and NO is this setting and demonstrates
that ONOO-, but not NO radical, induces apoptosis in
human MDMϕ. Furthermore, our data demonstrate for
the first time that the pro-apoptotic effects of ONOO- are
limited in human macrophages by pre-conditioning the
cells with agents that act to elevate intracellular concentra-
tions of cGMP.
During inflammation, neutrophilic leukocytes are
recruited and activated during an initial wave of inflam-
matory cell recruitment. These inflammatory cells gener-
ate reactive oxygen and nitrogen species, which can
combine to form ONOO- [39], thus resulting in a pro-oxi-
dising environment within the inflammatory site. A sec-
ond wave of cellular recruitment then results in an influx
of monocytes that differentiate within the inflammatory
Oxidising radical generation by GEA-3162Figure 2
Oxidising radical generation by GEA-3162. A – repre-
sentative EPR spectra generated by GEA-3162 (300 μM) in 
the presence and absence of SOD (500 U.ml-1). B – SOD 
reduced the intensity of the GEA-3162 EPR signal by a maxi-
mum of 61%. *P < 0.05, ***P < 0.001 (Two-way ANOVA fol-
lowed by post hoc Bonferroni's test; n = 6).
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GEA-3162 induces apoptosis in human MDMϕFigure 3
GEA-3162 induces apoptosis in human MDMϕ. A – representative flow cytometry plots. B – induction of apoptosis by 
GEA-3162 but not DETA/NO. **P < 0.01 significantly greater annexin V binding compared to control; #P < 0.05 significantly 
greater PI staining compared to control (unpaired, one-way ANOVA followed by post hoc Dunnett's test; n = 6 – 9). C – 
apoptosis (annexin V binding; left panel) induced by GEA-3162 was elevated by SOD (500 U.ml-1). A combination of SOD and 
catalase (both 500 U.ml-1) blunted the SOD-induced elevation of apoptosis but not reduce GEA-3162-induced apoptosis. PI 
staining (right panel) was unaffected by SOD or catalase. **P < 0.01; matched two ANOVA followed by post hoc Bonferroni's 
test; n = 6.
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site into macrophages. These macrophages play a crucial
role in phagocytosing and removing apoptotic cells dur-
ing the resolution of inflammation and tissue healing
[40,41]. Macrophages resident in an inflammatory site
will therefore be exposed to pro-apoptotic oxidising spe-
cies, including ONOO-, generated during the inflamma-
tory process.
In agreement with previous studies [21], our electrochem-
istry and EPR studies confirm that GEA-3162 decomposes
to co-generate NO and O2•-, and is therefore a ONOO-
generator, whilst DETA/NO liberates NO radicals in solu-
tion. In subsequent experiments, only ONOO- induced
apoptosis, and the level of apoptosis induced was related
to the activity of the compound. ONOO- is well docu-
mented to be cytotoxic in many cell types [42,43]. How-
ever, although ONOO- has previously been demonstrated
to be pro-apoptotic in several cell types, including murine
macrophages [44,45], this is the first report of ONOO-
inducing apoptosis in human macrophages. Interestingly,
in contrast to the actions of ONOO-, NO radical had no
affect on cell viability. It is particularly surprising that NO
radical was so ineffectual at causing either apoptosis or
necrosis, even at these supraphysiological concentrations;
this is in direct contrast to the observations of others who
have demonstrated NO-induced apoptosis in a variety of
inflammatory cells, including neutrophils [46] and
murine, but not human, macrophages [9,47]. This dispar-
ity between the ability of ONOO- and NO to induce apop-
tosis may go some way to rationalise the apparently
paradoxical reports of NO being both pro- and anti-apop-
totic. Our results suggest that it is NO-related species, and
ONOO- in particular, which might be formed in the
microenvironment of the cell, that are responsible for pro-
apoptotic signalling in human macrophages.
In rat thymocytes ONOO--induced apoptosis was inhib-
ited by the antioxidant, Trolox, indicating that oxidising
species are the apoptotic trigger [48]. We observed that the
anti-oxidant and O2•- scavenger, SOD, actually elevated,
rather than inhibited, ONOO--mediated apoptosis. As our
electrochemical data demonstrate, in both the absence
and presence of cells, SOD effectively 'unmasks' NO pro-
duction from GEA-3162 by removing O2- from the system.
Therefore, the NO liberated from GEA-3162 in the pres-
ence of SOD could itself be pro-apoptotic. However, given
that we found that far higher NO concentrations released
from DETA/NO failed to induce apoptosis, perhaps a
more likely explanation is that hydrogen peroxide
(H2O2), formed by SOD [49] during the enzymatic con-
version of O2•-, is a more effective mediator of apoptosis
than ONOO- per se. Indeed, H2O2 has previously been
shown to be responsible for NO-induced apoptosis in
murine macrophages by activating pro-apoptotic caspase
enzymes [50]. Although H2O2 can inhibit caspase
enzymes under certain circumstances, this usually occurs
at very high H2O2 concentrations (higher that those likely
to be generated in our experiments), and only once apop-
tosis has already been initiated [51]. Furthermore, inhibi-
tion of caspases once apoptosis has been initiated results
in a switch from apoptosis to necrosis, which did not
occur in this study. It is therefore possible that H2O2
would activate, rather than inhibit, caspase enzymes in
our study. If H2O2 were formed by SOD in our experimen-
tal system, it would be predicted that a combination of
cGMP signalling inhibits apoptosisFigure 4
cGMP signalling inhibits apoptosis. MDMϕ were sub-
jected to 24 h pre-treatment as shown below each column. A 
– The pre-treatments had no effect on cell viability after 24 h 
compared to vehicle (1% DMSO) treated cells (first column). 
B – The groups indicated were then treated for a further 24 
h with GEA-3162 (100 μM). Pre-treatment with 8-bromo-
cGMP, 300 μM DETA/NO, and 10 μM DETA/NO in combi-
nation with BAY 41–2272 or IBMX, all significantly attenu-
ated GEA-3162-induced apoptosis. ODQ prevented the 
attenuation of apoptosis induced by 300 μM DETA/NO. **P 
< 0.01 significantly different from vehicle (1% DMSO) treated 
control cells (first column). #P < 0.01 significantly different 
from GEA-3162 treated cells (second column; one-way 
ANOVA followed by post hoc Dunnet's test; n = 3 – 9).
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SOD plus catalase (to eliminate H2O2) would inhibit
overall levels of apoptosis. However, although the SOD-
induced elevation of apoptosis was blunted by catalase,
overall levels of GEA-3162-induced apoptosis were not
inhibited by a combination of SOD plus catalase. The rea-
sons for this are not entirely clear, however, it has been
reported that the enzymatic activity of catalase can be
inhibited by NO via interactions with the ferric group of
the enzyme [52,53]. It is therefore possible that catalase
becomes inhibited by the NO unmasked from GEA-3162
in the presence of SOD and so cannot breakdown H2O2,
thus apoptosis is not inhibited.
Earlier reports on the anti-apoptotic actions of NO in
murine cells suggested that resistance to pro-apoptotic sig-
nals from NO, and/or NO-related species, may be a pre-
conditioning response dependent on the anti-apoptotic
properties of cGMP produced in response to the NO itself
[23-25]. In common with these observations, our findings
demonstrate that ONOO--induced apoptosis is attenu-
ated in human MDMϕ following prior incubation with a
low concentration of NO radical in combination with
BAY 41–2272 (a sGC stimulator) to augment cGMP pro-
duction, or with IBMX (a PDE inhibitor) to prevent cGMP
breakdown. Similarly, the cell permeable cGMP analogue,
8-bromo-cGMP, and a higher concentration of the NO
donor compound, DETA/NO, also reduced apoptosis fol-
lowing subsequent exposure to ONOO-. As the cGMP-ele-
vating agents were washed out of the cells in advance of
ONOO- treatment, we believe this to be a cGMP-depend-
ent pre-conditioning mechanism that protects human
MDMϕ from subsequent apoptosis. That this pre-condi-
tioning response is dependent on cGMP signalling, rather
than NO radicals per se, is further underlined by the obser-
vation that the sGC inhibitor, ODQ, reversed the protec-
tion against ONOO--induced apoptosis afforded by
higher concentrations of DETA/NO.
In rodent macrophages, the observation that cGMP
primes cells against subsequent pro-apoptotic signals has
been proposed as a self-defence mechanism against high
iNOS-derived NO concentrations generated by macro-
phages during host defence against invading pathogens
[24,25]. Recently, it was reported that eNOS-derived NO
plays a critical role in promoting iNOS induction and
function in response to lipopolysaccharide (LPS) treat-
ment in rodent macrophages and blood vessels [54,55].
Thus, it appears that during host defence, auto-regulation
between NOS isoforms allows lower concentrations of
NO to induce the production of supraphysiological NO
concentrations whilst simultaneously affording cGMP-
dependent cellular protection against these high NO con-
centrations. Therefore it seems that NO is able to provide
the cell with a means to finely balance pro- and anti-
apoptotic NO signals. However, because NO production
by human macrophages is either absent or exceedingly
low [56-58], self-defence is unlikely to account for the
phenomenon in human cells. The studies conducted in
murine cells used relatively high concentrations (~100
μM) of NO donor compounds to induce cytoprotection
and crucially, the concentration of NO radical generated
by the NO donor compounds was not measured in such
studies. From our electrochemistry data we have esti-
mated that the concentration of NO released from 10 μM
DETA/NO is likely to be in the nM range and arguably a
more realistically physiological model of endogenous
endothelial-derived NO. Our observations in human cells
could, therefore, represent a cGMP-dependent mecha-
nism by which, in the disease-free state, eNOS-derived
NO from the healthy endothelium is able to limit apopto-
sis in macrophages. Protecting macrophages against the
pro-apoptotic oxidising milieu of an inflammatory site
would ensure maintenance of a sufficient population of
phagocytes to effectively remove those cells that have
undergone apoptosis, thus promoting the successful reso-
lution of inflammation and preventing the tissue damage
that can occur when apoptotic cells remaining in situ even-
tually rupture their membranes and release their histo-
toxic contents causing widespread necrosis [59].
The downstream signalling events responsible for cGMP-
dependent inhibition of apoptosis in human MDMϕ
remain to be elucidated. Apoptosis involves multiple
pathways and signalling cascades and is controlled by the
regulation of various pro- and anti-apoptotic factors
within the cell. It is likely that cGMP, possibly via activa-
tion of protein kinase G (PKG; [24]) ultimately results in
a shift in the pro-/anti- apoptotic balance of the cell in
favour of the later.
In summary, we have demonstrated the differential ability
of NO and NO-related species to induce apoptosis in
human MDMϕ, and have established that ONOO-, but
not NO radical, is pro-apoptotic in this cell type (figure 5).
Furthermore, our results demonstrate the presence of a
cGMP-dependent pre-conditioning mechanism to limit
ONOO--induced apoptosis in human macrophages.
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